Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ProMIS Neurosciences Inc.Listing on record | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC | |
ProMIS Neurosciences Inc.Listing on record | Buy | $8.5M | conv 68First in 12mo | SEC | |
ABG Acquisition Corp. IListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ABG Acquisition Corp. IListing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
East Stone Acquisition CorpListing unverified | Sell | n/a (No price was disclosed in the filing) | SEC | ||
ABG Acquisition Corp. IListing unverified | Other | $393K | SEC | ||
East Stone Acquisition CorpListing unverified | Buy | $1.7M | conv 54ClusterFirst in 12mo | SEC | |
Sorrento Therapeutics, Inc.Listing on record | Sell | $1.1M | SEC | ||
Sorrento Therapeutics, Inc.Listing on record | Sell | $3.5M | SEC | ||
BIOCEPT INCListing on record | Other | $964K | SEC | ||
BIOCEPT INCListing on record | Other | $280.4K | SEC | ||
BIOCEPT INCListing on record | Other | $604.7K | SEC |